Oral semaglutide vastly reduces heart attacks, strokes in people with type 2 diabetes. New England Journal of Medicine #ACC25
Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention for their effectiveness against weight gain, high blood sugar, and even alcohol cravings.…
For younger women, mental health now may predict heart health later #AAC24
Younger women are generally thought to have a low risk of heart disease, but new research urges clinicians to revisit that assumption, especially for women who suffer from certain mental…
Tools underestimate cardiovascular event risk in people with HIV #CROI2024
The elevated cardiovascular disease risk among people with HIV is even greater than predicted by a standard risk calculator in several groups, including Black people and cisgender women, according to…